Does RIBOCICLIB Cause Hepatic lesion? 144 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 144 reports of Hepatic lesion have been filed in association with RIBOCICLIB (KISQALI). This represents 0.5% of all adverse event reports for RIBOCICLIB.
144
Reports of Hepatic lesion with RIBOCICLIB
0.5%
of all RIBOCICLIB reports
11
Deaths
17
Hospitalizations
How Dangerous Is Hepatic lesion From RIBOCICLIB?
Of the 144 reports, 11 (7.6%) resulted in death, 17 (11.8%) required hospitalization, and 1 (0.7%) were considered life-threatening.
Is Hepatic lesion Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 144 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Hepatic lesion?
OCTREOTIDE (296)
EVEROLIMUS (171)
LETROZOLE (139)
CAPECITABINE (124)
ADALIMUMAB (123)
METHOTREXATE (108)
FULVESTRANT (107)
PALBOCICLIB (104)
CYCLOPHOSPHAMIDE (101)
ZOLEDRONIC ACID (97)
Which RIBOCICLIB Alternatives Have Lower Hepatic lesion Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN